COVID-19 大流行对皮肤黑色素瘤诊断的影响:来自五个欧洲皮肤癌参考中心的回顾性队列研究
该回顾性队列研究收集了瑞士、德国、奥地利和意大利五个欧洲皮肤癌参考中心2018年9月1日至2021年8月31日间的7865例皮肤黑色素瘤病例,按各国限制措施将时段分为COVID前和COVID后。结果显示COVID后Breslow肿瘤厚度均值升高(1.25 mm vs 1.02 mm),T3-T4期黑色素瘤比例、溃疡率和核分裂率≥2的数目均增加(均p<0.001)。作者认为研究证实了COVID-19封锁导致的皮肤黑色素瘤诊断延迟,并指出需更长期随访研究评估其长期结局后果。
要点
- COVID后期间Breslow肿瘤厚度均值升高(1.25 mm vs 1.02 mm,p<0.001)。
- COVID后T3-T4期黑色素瘤比例、溃疡率和核分裂率≥2的数目均增加(均p<0.001)。
- 有免疫抑制和个人黑色素瘤史的患者在封锁及COVID后期间平均log10转化Breslow厚度下降。
核心结论
- 研究证实了COVID-19封锁导致的皮肤黑色素瘤诊断延迟。
- 高危个体如有个人黑色素瘤史者和老年人在COVID后更犹豫重启常规皮肤癌筛查。
- 需要更长期随访的进一步研究来评估这种诊断延迟对长期结局的后果。
研究设计与样本
- 回顾性队列研究,收集2018年9月1日至2021年8月31日间五个欧洲皮肤癌参考中心(位于瑞士、德国、奥地利和意大利)的7865例皮肤黑色素瘤病例。
- 按各国既定限制措施将时段分为COVID前(封锁前)和COVID后(封锁及封锁后)。
- 数据收集包括组织学确诊皮肤黑色素瘤的人口学、临床和组织病理学数据。
- 使用个人和家族黑色素瘤史及免疫抑制状态评估高危个体的诊断延迟。
主要发现
- COVID后期间Breslow肿瘤厚度均值较COVID前升高(1.25 mm vs 1.02 mm,p<0.001)。
- COVID后期间T3-T4期黑色素瘤比例、溃疡率和核分裂率≥2的数目均增加(均p<0.001)。
- 有免疫抑制和个人黑色素瘤史的患者在封锁及COVID后期间平均log10转化Breslow厚度下降。
- 多因素分析中,黑色素瘤诊断时年龄(p<0.01)和个人黑色素瘤史(p<0.01)在平均Breslow厚度上显示显著差异。
局限性
- 需要更长期随访的进一步研究来评估这种诊断延迟对长期结局的后果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The COVID-19 lockdown had a dramatic impact on primary care access and resulted in postponed skin cancer screenings. This raises concerns for a diagnostic delay on primary cutaneous melanomas, which can subsequently increase morbidity and mortality. OBJECTIVES: The aim of the study was to investigate the impact of the COVID-19-related restrictions on the melanoma diagnosis in five European skin cancer reference centres in Switzerland, Germany, Austria and Italy. METHODS: A total of 7865 cutaneous melanoma cases were collected between 01 September 2018 and 31 August 2021. The time period was stratified into pre-COVID (pre-lockdown) and post-COVID (lockdown and post-lockdown) according to the established restrictions in each country. The data collection included demographic, clinical and histopathological data from histologically confirmed cutaneous melanomas. Personal and family history of melanoma, and presence of immunosuppression were used to assess the diagnosis delay in high-risk individuals. RESULTS: There was an overall increase of the Breslow tumour thickness (mean 1.25 mm vs. 1.02 mm) during the post-COVID period, as well as an increase in the proportion of T3-T4 melanomas, rates of ulceration and the number of mitotic rates ≥2 (all, p < 0.001). Patients with immunosuppression and personal history of melanoma showed a decrease in the mean log10-transformed Breslow during lockdown and post-COVID. In the multivariate analysis, age at melanoma diagnosis (p < 0.01) and personal history of melanoma (p < 0.01) showed significant differences in the mean Breslow thickness. CONCLUSIONS: The study confirms the diagnostic delay in cutaneous melanomas due to the COVID-19 lockdown. High-risk individuals, such as patients with personal history of melanoma and elderly individuals, were more hesitant to restart their regular skin cancer screenings post-COVID. Further studies with longer follow-up are required to evaluate the consequences of this diagnostic delay in long-term outcomes.
引用
- Troesch A, Hoellwerth M, Forchhammer S, et al. The impact of the COVID-19 pandemic on the diagnosis of cutaneous melanomas: A retrospective cohort study from five European skin cancer reference centres. J Eur Acad Dermatol Venereol. 2023. PMID: 36785973. doi:10.1111/jdv.18953
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。